National OCS™ Program

Growing transplant volumes in the U.S.

donor organs clinically managed and transported for transplant since 2022

OCS™ Heart and Lung Programs at ISHLT 2023, Denver

OCS™ Heart & Lung Related Presentations at ISHLT:

Wednesday, April 19, 2023

  • First Report of the Organ Care System (OCS) Thoracic Organ Perfusion (TOP) Post-Approval Registry
    G. Loor | 1:30 -1:40 p.m. | Rooms 405-407
  • 476 – From Vpra of 100% to Transplantation, Journey of the First OCS-DBD Case in Switzerland
    B. Schnegg | 6:30 – 7:30 p.m. | Poster session | Mile High Ballroom
  • 620 – First Report of the Transmedics Organ Care System Heart Perfusion Registry. A Multi-Institutional Outcomes
    Analysis J. Stehlik | 6:30 – 7:30 p.m. | Poster session | Mile High Ballroom
  • 622 – First Report of the National OCS Program (NOP) in U.S. Heart and Lung Transplants
    W. Hassanein | 6:30 – 7:30 p.m. | Poster session | Mile High Ballroom
Thursday, April 20, 2023
  • Graft Preservation in Heart Transplantation: Clinical and Historical Results Using Three Different Techniques
    A Lechiancole | 4:33 – 4:37 p.m. | Rooms 603-605
  • 900 – Impact of National OCS Lung Procurement & Management Program on Post-Transplant Survival – Real World Data from the Thoracic Organ Perfusion (TOP) Post-Approval Registry
    S. Huddleston | 4:15 -5:15 p.m. | Poster session | Mile High Ballroom
  • 902 – Impact of National OCS Lung Warm Perfusion Times on Post-Transplant Survival – “Real-World” Experience from Thoracic Organ Perfusion (TOP) Registry
    G. Loor | 4:15 -5:15 p.m. | Poster session | Mile High Ballroom
Friday, April 21, 2023
  • Heart Donation and Transplantation of Circulatory Death Donors: The Dutch Experience
    N. P. van der Kaaij | 9:45 – 9:55 a.m. | Rooms 405-407
  • Demographics and Outcomes of Clinical Trial vs Initial Post-Approval Use of Transmedics Organ Care System Heart
    C. Milano | 10:00 – 10:10 a.m. | Rooms 405-407
  • Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience
    M. Franz | 10:15 – 10:25 a.m. | Rooms 405-407

During ISHLT, please join us for two symposia on revolutionizing organ transplantation:

Transplant Reimbursement and Economics Landscape for OCS Perfusion and NOP Services

Wednesday, April 19th, 11:30-12:30
Colorado Convention Center, Room 405-407

Moderators
  • Puneet Garcha, MD – Baylor St. Luke’s Medical Center, Houston TX
  • Paul Myoung, Executive Director Transplant Institute – Massachusetts General Hospital, Boston MA
Agenda Talks
  • Real World Overview of OCS Reimbursement and Economic Value to Engage with Payors – Having the Midas Touch – Kimberly Nicoll, VP US Transplant Reimbursement – TransMedics, Inc., Boston MA
  • Overview of CMS Transplant Reimbursement via Cost Report – Facts vs. Fiction – Robert Howey, MBA, Senior Government Reimbursement Consultant – Toyon Associates, Inc., Franklin TN
  • Establishing OCS NOP Transplant Consortiums and National Transplant Administration Working Group – Waleed Hassanein, MD – TransMedics, Inc., Boston MA
  • National Transplant Administration Working Group Panel Discussion and Q&A – Moderators
    • Paul Myoung, Executive Director Transplant Institute – Massachusetts General Hospital, Boston MA
    • Kimberly Nicoll, VP US Transplant Reimbursement – TransMedics Inc.
    • Robert Howey, Senior Government Reimbursement Consultant – Toyon Associates
    • Christopher Fowler, Transplant Operations Administrator – Mayo Clinic AZ
    • Liz Reed, VP Transplant Administration – Transplant Institute at Henry Ford Hospital

TransMedics Organ Care System (OCS™) State of the Art Heart and Lung Perfusion & Assessment Symposium – Transforming The Standard of Care

Thursday, April 20th • 11:30-12:30 PM
Colorado Convention Center, Room 401-404

Moderators
  • Kenneth McCurry, MD – Cleveland Clinic Foundation, Cleveland OH
  • Carmelo Milano, MD – Duke University Medical Center, Durham NC
Agenda Talks
  • Impact of OCS Lung Perfusion Times on Post-Transplant Clinical Outcomes – Real-World Data from Thoracic Organ Perfusion (TOP) Registry – Gabriel Loor, MD – Baylor St. Luke’s Medical Center, Houston TX
  • First Annual Report from The OCS Heart Perfusion (OHP) Registry in the USA – Post-Approval Clinical Experience – Josef Stehlik, MD – University of Utah Health, Salt Lake City UT
  • Standardized National Lung Procurement and OCS Perfusion Management (NOP) vs. Center Specific Process – Impact on Outcomes – Stephen Huddleston, MD – University of Minnesota, Minneapolis MN
  • Update on Long-Term Clinical Outcomes from OCS DCD Heart Pivotal Trial – Amy Fiedler, MD – University of California San Francisco, San Francisco CA
  • First Year Performance Review of The US National OCS Program (NOP) for Cardiothoracic Transplants – Waleed Hassanein, MD – TransMedics, Inc., Andover MA
  • Panel Discussion and Q&A – Moderators
WordPress Lightbox